A Conference Review: ISSCR2024
July 30, 2024
Once again, scientists, researchers, engineers, and pioneers from across the globe gathered to discuss, collaborate, and learn about the forefront of stem cell research at
Once again, scientists, researchers, engineers, and pioneers from across the globe gathered to discuss, collaborate, and learn about the forefront of stem cell research at
Stem cell specialists StemCultures and growth factor manufacturer Qkine will develop new controlled-release growth factors that allow fine control of stem cell expansion and differentiation
Over the past year, StemCultures has had the opportunity to grow and engage with customers and strategic partners across the world. StemCultures brought the public
Properly maintained systems require direction and organization to operate effectively. Often, this is accomplished through accurate communication, with an initial instruction to start a specific
The biotechnology industry has created a lot of buzz over the last several decades as new medical advancements and therapeutic developments have begun to change
Our Co-Founder and President, Dr. Sally Temple, has been elected to the National Academy of Medicine Class of 2022. Dr. Temple joins the 2,200 others
StemCultures Celebrates 10 Years of Controlled Growth Factor Delivery and Innovative Discovery Scientific discovery answers life’s challenging questions. A problem is identified, and a solution
China was a tempting location for StemCultures to offshore its manufacturing to, but this Rensselaer company abandoned its exploration to do so despite already offshoring
NIH Award for StemCultures In fiscal 2021, 16 local firms and institutions received $73.6 million from 152 NIH awards. That included more than $3.2 million
The DISC™ device releases FGF2 at a controlled rate, minimizing variations in concentration and providing stable FGF2 levels with improved control for higher quality cultures